Arterial stiffness is not increased in patients with short duration rheumatoid arthritis and ankylosing spondylitis

References

• Kremers HM, Crowson CS, Therneau TM, et al. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008;58:2268–2274.
   PubMed Web of Science ®Google Scholar
• Mathieu S, Motreff P, Soubrier M. Spondyloarthropathies: an independent cardiovascular risk factor? Joint Bone Spine. 2010;77:542–545.
   PubMed Web of Science ®Google Scholar
• Han C, Robinson DW Jr, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167–2172.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Tasso M, Lupoli R, et al. Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies. Ann Med. 2015;47:457–467.
   PubMed Web of Science ®Google Scholar
• Soltesz P, Kerekes G, Der H, et al. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev. 2011;10:416–425.
   PubMed Web of Science ®Google Scholar
• Sandoo A, Chanchlani N, Hodson J, et al. The relationship between cardiovascular disease risk prediction scores and vascular function and morphology in rheumatoid arthritis. Clin Exp Rheumatol. 2014;32:914–921.
   PubMed Web of Science ®Google Scholar
• Montecucco F, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology. 2009;48:11–22.
   PubMed Web of Science ®Google Scholar
• Klimek E, Skalska A, Kwasny-Krochin B, et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediators Inflamm. 2014;2014:681635.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Lupoli R, Di Minno A, et al. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost. 2015;113:916–930.
   PubMed Web of Science ®Google Scholar
• Sodergren A, Karp K, Boman K, et al. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther. 2010;12:R158.
   PubMed Web of Science ®Google Scholar
• Chatterjee Adhikari M, Guin A, Chakraborty S, et al. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum. 2012;41:669–675.
   PubMed Web of Science ®Google Scholar
• van Eijk IC, Serne EH, Dijkmans BA, et al. Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity. Clin Rheumatol. 2011;30:1113–1118.
   PubMed Web of Science ®Google Scholar
• Turkyilmaz AK, Devrimsel G, Kirbas A, et al. Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int. 2013;33:2751–2756.
   PubMed Web of Science ®Google Scholar
• Kocabay G, Hasdemir H, Yildiz M. Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behçet’s disease. J Cardiol. 2012;59:72–77.
   PubMed Web of Science ®Google Scholar
• Avalos I, Chung CP, Oeser A, et al. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol. 2007;34:2388–2394.
   PubMed Web of Science ®Google Scholar
• Provan SA, Angel K, Semb AG, et al. Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year follow-up study of 108 patients with rheumatoid arthritis. J Rheumatol. 2011;38:606–612.
   PubMed Web of Science ®Google Scholar
• Mathieu S, Joly H, Baron G, et al. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology. 2008;47:1203–1207.
   PubMed Web of Science ®Google Scholar
• Bodnar N, Kerekes G, Seres I, et al. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol. 2011;38:723–729.
   PubMed Web of Science ®Google Scholar
• van Eijk IC, Peters MJ, Serne EH, et al. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis. 2009;68:362–366.
   PubMed Web of Science ®Google Scholar
• Berg IJ, van der Heijde D, Dagfinrud H, et al. Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J Rheumatol. 2015;42:645–653.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–1327.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, O’Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865–1871.
   PubMed Web of Science ®Google Scholar
• Klimek E, Mikolajczyk T, Sulicka J, et al. Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity. Biomed Res Int. 2014;2014:736853.
   PubMed Web of Science ®Google Scholar
• Surdacki A, Sulicka J, Korkosz M, et al. Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis. J Rheumatol. 2014;41:481–489.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–368.
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Iervolino S, Lupoli R, et al. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost. 2012;38:497–505.
   PubMed Web of Science ®Google Scholar
• Sandoo A, Veldhuijzen van Zanten JJ, Metsios GS, et al. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology. 2011;50:2125–2139.
   PubMed Web of Science ®Google Scholar
• Lo Gullo A, Mandraffino G, Imbalzano E, et al. Toll-like receptor 3 and interleukin 1β expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement. Clin Exp Rheumatol. 2014;32:922–929.
   PubMed Web of Science ®Google Scholar
• Chung CP, Oeser A, Raggi P, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005;52:3045–3053.
   PubMed Web of Science ®Google Scholar
• Arts EE, Fransen J, den Broeder AA, et al. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Ann Rheum Dis. 2015;74:998–1003.
   PubMed Web of Science ®Google Scholar
• Tam LS, Kitas GD, Gonzalez-Gay MA. Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology. 2014;53:1108–1119.
   PubMed Web of Science ®Google Scholar
• Sandoo A, Kitas GD, Carroll D, et al. The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther. 2012;14:R117.
   PubMed Web of Science ®Google Scholar
• Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis. 2009;68:460–469.
   PubMed Web of Science ®Google Scholar